Topics
March 2016 | cover Focus:a Brighter Future For Diabetic Eye Disease
Identifying and Monitoring Diabetic Retinopathy
Recognizing the strengths and drawbacks of different imaging modalities for managing patients with diabetic eye disease.
David A. Salz, MD, and Andre J. Witkin, MD
August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
August 5, 2026
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy
August 4, 2026
University of Iowa Research Underpins First-in-Human UK Study of Gene Therapy Targeting Rare IRD
Swedish Study Finds Small Absolute Risk of NAION Among GLP-1 Receptor Agonist Users
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
